11 C-Pittsburgh Compound B ( 11 C-PiB) PET has demonstrated significantly higher PiB retention in the gray matter of Alzheimer disease (AD) patients than in healthy controls (HCs). PiB is similarly retained within the white matter of HC and AD brains. Although the specificity of PiB for Ab plaques in gray matter has been well described, the nature of PiB binding to white matter remains unclear. In this study, we characterized the binding of PiB to human white matter homogenates. Methods: In vitro binding studies were conducted using 3 H-PiB (0.1-500 nM) and white matter brain homogenates (100 mg) from 3 AD patients and 3 HCs. Nonspecific binding was determined using PiB (1 mM). White matter from the same patients was also analyzed by immunofluorescence/immunohistochemistry (IF/IHC) microscopy and Western blotting for Ab expression. White matter kinetics were also characterized in vivo through 11 C-PiB PET studies in 27 HCs and 34 patients with dementia. IF/IHC experiments were conducted on 1 postmortem patient with dementia, to compare with the 11 C-PiB distribution volume ratio data acquired 23 mo earlier. Results: In vitro saturation studies indicated that 3 HPiB binds nonspecifically to white matter brain homogenates. PiB fluorescence staining of AD and HC brain sections was consistent with absence of Ab in IHC staining. Higher gray matterto-white matter ratios were observed in IHC images than in 11 C-PiB PET images. Conclusion: These studies suggest that PiB binding to white matter is mainly nonsaturable and nonspecific and that PiB retention in the 11 C-PiB PET studies is largely attributable to slower PiB white matter kinetics.
Pi ttsburgh Compound B (PiB; 2-(49-methylaminophenyl)-6-hydroxybenzothiazole, or 6-OH-BTA-1), a derivative of thioflavin T, has been successfully used as a PET ligand to assess Ab deposition. PiB has provided quantitative information on Ab burden, leading to new insights into Ab deposition in the brain and facilitating research of neurodegenerative disease in which Ab may play a role (1) (2) (3) (4) . PET studies have shown not only a robust difference in 11 CPiB retention between age-matched healthy controls (HCs) and Alzheimer disease (AD) patients (1,2,5) but also inverse correlations with glucose hypometabolism (2, 6) and decreased cerebrospinal fluid Ab 42 (7) and rate of cerebral atrophy (as measured by MRI) (8) . Furthermore, comparison of the diagnostic utility of Ab versus 18 F-FDG imaging demonstrated that PiB imaging is more accurate than is 18 F-FDG for the diagnosis of AD (9) . Studies in patients with dementia with Lewy bodies (DLB) demonstrated an 11 CPiB retention pattern similar to that of AD patients (1) . Nonetheless, average 11 C-PiB PET retention in DLB brains was lower, reflecting a larger spectrum of Ab deposition (1) . Interestingly, about 20%-25% of the cognitively normal elderly subjects who were evaluated showed cortical binding predominantly in the prefrontal and posterior cingulate/ precuneus regions, though to a lesser degree than did AD patients (1, 10, 11) .
Despite the evidence demonstrating the specificity of PiB for Ab plaques, critical analysis of 11 C-PiB PET studies has warranted further investigations. First, the contribution of Lewy bodies (LBs) to 11 C-PiB PET retention in DLB patients has been studied. LBs are primarily composed of aggregated a-synuclein and, like Ab, are thioflavin T-positive. Moreover, LBs reside in the same cortical brain regions as do Ab plaques. We characterized 3 H-PiB binding to a-synuclein fibrils and LBs (12) . Although 3 H-PiB binds to a-synuclein fibrils with lower affinity than to Ab 1-42 fibrils, the concentration of a-synuclein fibrils required for significant 3 H-PiB binding is physiologically unattainable. Image quantification suggested that both the small size and low number of LBs present within cortical regions of DLB brains would make negligible their contribution to the 11 C-PiB PET signal (12) . Second, further research is warranted because of the apparent higher PiB retention in the white matter of HCs.
PiB retention has been reported to be equivalent in the white matter (a brain region relatively unaffected by amyloid deposition) of AD patients and HCs (2) . To date, the specificity of PiB binding to white matter has not been examined. The aim of the present study was to characterize the in vitro and in vivo binding of PiB to white matter.
MATERIALS AND METHODS

Chemicals
All reagents were purchased from Sigma, unless otherwise stated. 3 H-2-(49-methylaminophenyl)-6-hydroxybenzothiazole ( 3 H-PiB; purity, .97%; specific activity, 2,679 GBq/mmol) was sourced from American Radiolabeled Chemicals. Unlabeled PiB was custom-synthesized, purified, and analyzed as described previously (13) . Human Ab 1-42 was purchased from W.M. Keck Laboratory.
Tissue Collection and Characterization
Brain tissue was collected at autopsy. Sourcing and preparation of human brain tissue was conducted by the National Neural Tissue Resource Centre. AD pathologic diagnosis was made according to standard National Institute on Aging-Reagan Institute criteria (14) . Determination of age-matched HC cases was subject to the above criteria. The number of subjects is indicated in the figures and tables.
Preparation of Human Brain Tissue for In Vitro Binding Studies
Gray (frontal cortex) and white matter (centrum semiovale) was isolated from postmortem AD patients and HCs. Tissue was homogenized in 1· phosphate-buffered saline (PBS) (without calcium and magnesium), using an ultrasonic cell disrupter (2 · 30 s, 24,000 rpm) (Virsonic 600; Virtis). Protein concentration was determined (bicinchoninic acid assay), and brain homogenates were separated into aliquots and frozen (280°C).
ELISA
Brain Ab levels were determined using the DELFIA Double Capture ELISA (PerkinElmer), as previously described (15) . Brain tissue, as prepared above, was solubilized with guanidine hydrogen chloride (5 M), followed by centrifugation (16,000g for 20 min). Supernatants were then diluted 1:10 with blocking buffer (0.25% casein or Superblock [Thermo Fisher Scientific Inc.] in PBS, with 0.025% polysorbate-20), and aliquots were placed onto the plate. Plates were incubated with either G210 (to detect Ab 1-40 ) or G211 (Ab 1-42 ) antibodies and then blocked with 0.5% (w/v) casein and PBS or Superblock and PBS buffer (pH 7.4). After washing, WO2-biotin was added. Ab and Ab 1-42 peptide standards and samples were assayed in triplicate and incubated overnight (4°C). Plates were washed, and europium-labeled streptavidin was added and developed with enhancement solution. Analysis was performed using the Wallac Multilabel Plate Reader (PerkinElmer), with excitation and emission at 340 and 613 nm, respectively.
In Vitro PiB Binding Assays AD and age-matched control brain homogenates (100 mg) were incubated with increasing concentrations of 3 H-PiB (0.1-200 nM; specific activity, 2,679 GBq/mmol). Nonspecific binding was accounted for using unlabeled PiB (1 mM). Binding reactions were incubated at room temperature for 3 h in 200 mL of assay buffer (PBS, minus magnesium and calcium ions [JRH Biosciences] and 0.1% bovine serum albumin). Bound radioactivity was separated from free radioactivity by filtration under reduced pressure (MultiScreen HTS Vacuum Manifold and MultiScreen HTS 96-well filtration plates [0.65 mm]; Millipore). Filters were washed 3 times with 200 mL of assay buffer and incubated overnight in 3 mL of scintillation fluid (Emulsifier Safe Scintillation cocktail; PerkinElmer). Samples were counted in a b-counter (LS6500; Beckman Coulter). Binding data were analyzed with curve-fitting software (version 1.0, GraphPad Prism; GraphPad Software). All experiments were conducted in triplicate.
Immunohistochemistry (IHC) and Immunofluorescence (IF) Analysis
The brain sections (frontal cortex or centrum semiovale) of AD patients and HCs were fixed (10% formalin/PBS) and embedded in paraffin. Serial sections (7 mm) were freed of paraffin and treated with 80% formic acid (5 min), and endogenous peroxidase activity was blocked (3% hydrogen peroxide). Sections were blocked (20% fetal calf serum, 50 mM Tris-HCl, 175 mM sodium chloride, pH 7.4) before incubation with Ab (1E8; Ab epitope 17-22 (16)) primary antibody for 1 h at room temperature. Antibody reactivity was visualized using a labeled streptavidin-biotin kit (Dako), and hydrogen-peroxidase-diaminobenzidine was used to visualize Ab-positive deposits. The second serial section was stained with PiB. This section was freed of paraffin and autofluorescence was quenched (0.25% potassium permanganate/PBS, 20 min; 1% potassium metabisulfite/1% oxalic acid/PBS, 5 min). Sections were blocked in 2% bovine serum albumin/PBS (pH 7.0, 10 min) and stained with 100 mM PiB for 30 min. Washed (PBS) sections were mounted in nonfluorescent mounting medium (Dako), and stained tissue sections were analyzed using a microscope (model DM1RB; Leica). Colocalization of PiB and antibody signals was assessed by overlaying images from each of the stained serial tissue sections.
In Vivo Amyloid Imaging Studies
A total of 54 subjects (27 HCs and 17 AD and 10 DLB patients) were recruited for the study and underwent 11 C-PiB PET scans. All AD and DLB patients met National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria and consensus criteria for probable AD (17) and DLB (18) diagnosis, respectively. Patients were recruited from the Austin Health Memory Disorders and Neurobehavioural Clinics. Written informed consent for participation in this study was obtained before the scan. Approval was obtained for the study from the Austin Health Human Research Ethics Committee, Austin Radiation Subcommittee, and the Victorian Department of Human Services Radiation Safety Unit. All subjects underwent 3-dimensional spoiled gradient echo T1-weighed MRI on a 1.5-T scanner (Sigma; GE Healthcare) for screening and subsequent coregistration with PET images. 11 C-PiB was produced in the Centre for PET, Austin Hospital, as previously described (1). Attenuation correction was performed using a rotation transmission sinogram acquisition in 3-dimensional mode, with a single 137 Cs point source, before the injection of the radiotracer. A 90-min list-mode emission acquisition was performed in 3-dimensional mode with a PET camera (Allegro; Phillips) after an intravenous injection of 11 C-PiB (375 6 18 MBq) (specific activity, 30 6 7.5 GBq/mmol [30,000 Gbq/mmol] (1)). List-mode raw data were sorted offline into 4 · 30 s, 9 · 1 min, 3 · 3 min, 10 · 6 min, and 2 · 10 min frames. The sorted sinograms were reconstructed using a 3-dimensional rowaction maximization-likelihood algorithm. Coregistration of the PET images with individual MR images was performed with statistical parametric mapping (SPM2; MRC Cognition and Brain Sciences Unit) (19) . Regions of interest (ROIs) were drawn on individual MR images and transferred to the coregistered PET images. Mean radioactivity values were obtained from the ROIs for cortical, subcortical, and white matter regions, and decaycorrected time-activity curves were generated. Distribution volume ratios (DVRs) were determined via graphical analysis (20) , using the cerebellar cortex as the input function (2, 20, 21) . The mean of the DVRs for frontal, cingulate, parietal, lateral temporal, and occipital cortices was calculated and termed neocortical DVR. Because there were no significant differences in DVR between the groups, brain clearances of the radiotracer were calculated by fitting all the regional radioactivity concentration values at the different time points to a triple-exponential equation:
where E is the brain radioactivity concentration, and A, B, and C are coefficients for the initial rapid distribution (a), distribution and disposition (b), and elimination (g) phases, respectively. The clearance half-life (t 1/2 ) was calculated as t 1/2 5 0.693/g.
Postmortem In Vivo Comparison
IF/IHC was compared with 11 C-PiB DVR in a DLB patient who had died 23 mo after the PET scan and whose brain was neuropathologically evaluated after autopsy. Images were quantified in the immunostained brain cortical (frontal and temporal cortex) and white matter (centrum semiovale) sections. Serial 5-mm tissue sections were immunostained with antibodies to Ab (1E8), a-synuclein (97/8 (22)), and tau-protein (Dako), as previously described (12) . A total of 45 high-resolution (;1.2 pixel/ mm), 24-bit red-green-blue color brain images, from 5 regions in each section, were acquired and digitized using an axiocam HRc (12-megapixel) color digital camera (Zeiss). Images were quantified using ImagePro Plus software (version 5.1; Media Cybernetics). For each image, an ROI was drawn around the margins of the brain tissue under the field of view. IHC-positive structures were identified, and thresholds were applied using color selection to separate plaques, neurofibrillary tangles, or Lewy bodies from background tissue. Only structures larger than 10 pixels were included. Data were expressed as the fraction of the area of IHC-positive pixels in each section to the total brain area in the same section.
Statistical Analysis
Descriptive statistics and ANOVA were performed to assess group differences in the in vitro studies. For PET studies, group differences were statistically evaluated using a Wilcoxon signed rank test followed by a Dunnet's test to compare each group with controls and a Tukey-Kramer honestly significant difference test to establish differences between group means. Correlations were assessed by Pearson product-moment or Spearman rank-order correlation analyses where appropriate.
RESULTS
In Vitro 3 H-PiB Binding Analysis of Human AD and HC Brains
In previous studies, postmortem brain homogenates have been used to characterize amyloid imaging agents (13, 23) . To determine the contribution of PiB binding to white matter in 11 C-PiB PET studies, 3 H-PiB binding to centrum semiovale homogenates was assessed. The centrum semiovale region was chosen to ensure no gray matter contamination. In parallel, the same experiments were repeated with gray matter homogenates (frontal cortex) from the same subjects. As previously reported, 3 H-PiB bound with high affinity to AD gray matter (Fig. 1A) (24) . Nevertheless, 3 H-PiB failed to show specific binding to HC gray matter (Fig. 1B) or to AD and HC white matter homogenates (Figs. 1C and 1D, respectively) . 3 H-PiB binding to AD gray matter homogenates was associated with the presence of Ab expression, as determined by ELISA (Table  1) and Western blot (data not shown). Furthermore, the absence of 3 H-PiB binding was consistent with negligible detection of Ab expression in these homogenates (Table 1) .
PiB and Immunohistochemical Staining of Human AD Patients and HCs
As a qualitative measure of PiB binding, unlabeled PiB (100 mM) staining of fixed tissue was compared with contiguous IHC-immunostained sections. As previously reported, AD frontal cortex sections exhibited numerous Ab plaques that colocalized with PiB staining ( Fig. 2A) (12) . The absence of Ab plaques was evident in the centrum semiovale sections from both AD and HC tissue sections (Figs. 2B and 2C, respectively) . Nevertheless, at high magnification, PiB staining of the centrum semiovale appeared to highlight blood vessels in both subjects.
In Vivo 11 C-PiB PET Group demographics are depicted in Table 2 . 11 C-PiB brain radioactivity peaked between 3 and 6 min after injection, and binding appeared to be reversible. 11 C-PiB cleared most quickly from the cerebellum and most slowly from the white matter (Fig. 3) . Clearance from the cerebellar cortex was the same for all groups, a finding that is consistent with the absence of neuritic Ab plaques in this region (25) . Although neocortical 11 C-PiB clearance was significantly slower in AD and DLB patients than in HCs, there were no differences in white matter clearance between the groups ( Table 2) .
As previously reported (1), AD patients showed marked cortical and caudate nucleus 11 C-PiB retention, with relative sparing of the sensorimotor cortex. DLB patients showed cortical 11 C-PiB retention similar to that of AD patients, albeit the degree of binding was generally lower and widely varied among DLB patients (Table 2) . Most HCs showed less 11 C-PiB retention in all cortical and subcortical gray matter areas, compared with white matter. Furthermore, 23% of HCs showed a range of higher cortical 
FIGURE 2. IHC and IF analysis indi-
cates PiB staining does not bind to white matter. Microscopy images of 2 serial sections (7 mm) from frontal cortex of AD patient (A) and centrum semiovale from age-matched HC (B) and AD patient (C). First section was immunostained with antibody to Ab (1E8) to identify Ab plaques; second serial section was stained with 100 mM PiB. Presence of Ab plaques was detected in AD frontal cortex sections (black arrowheads) and colocalized with positive PiB staining (white arrowheads). Centrum semiovale sections exhibited no immunoreactivity with 1E8, indicating absence of plaques (B and C). At higher magnification, PiB staining was observed to highlight blood vessels. (D) Serial sections (5 mm) isolated from gray matter (frontal cortex; top) and white matter (centrum semiovale; bottom) of patient with DLB who underwent 11 CPiB PET 23 mo before his death. Sections (from left to right) were stained with antibodies to Ab (1E8) to Ab plaques, PiB, a-syn (97/8), and tau-protein (Dako) and stained with PiB (100 mM). Presence of Ab plaques was detected in DLB frontal cortex sections and colocalized with positive PiB staining. Centrum semiovale sections exhibited no immunoreactivity with any reagent used, indicating absence of Ab plaques, Lewy bodies, or neurofibrillary tangles. Images were taken on Leica microscope. Scale bars, 50 mm. a-syn 5 a-synuclein.
11 C-PiB binding in gray matter (Table 2) . No correlation (r 5 0.12, P 5 0.32) was found between 11 C-PiB DVRs in the neocortex and white matter (data not shown).
IF/IHC analysis of brain sections from a DLB patient, who died 23 mo after an initial 11 C-PiB PET scan, indicated that the highest area of plaques was in the frontal cortex, with no plaques detected in the white matter (IHC-positive area fraction, 0.03 and 0.00, respectively) (Fig. 2D) . Although there were also LBs and even some neurofibrillary tangles present in other cortical areas (not shown), there were none in the white matter (Fig. 2D) . Although Ab plaques were not detectable by IHC or IF in white matter, 11 C-PiB standardized uptake values were only 11% higher in the neocortical gray matter areas than in the white matter (standardized uptake values, 1.48 and 1.33, respectively).
DISCUSSION
We used in vitro and in vivo methods to characterize 11 CPiB PET binding in white matter. In vitro approaches were used to assess whether 3 H-PiB specifically bound to brain homogenates or sections isolated from the centrum semiovale of AD patients and HCs. ELISA data suggested that the presence of Ab in the centrum semiovale was comparable to the levels of Ab detected in gray matter homogenates of HCs. Furthermore, the binding of 3 H-PiB to the centrum semiovale homogenates of both HCs and AD patients was nonsaturable. IHC experiments also indicated the absence of Ab neuritic or diffuse plaques in the centrum semiovale. Additionally, correlation of 11 C-PiB PET data with postmortem sections obtained almost 2 y after the PET scan suggested that 11 C-PiB PET retention in white matter was nonspecific binding, as, in addition to the notable absence of Ab plaques, PiB failed to stain the centrum semiovale brain sections obtained at autopsy.
Although the concentration of PiB used in IF experiments was considerably higher (100 mM) than the low nanomolar concentrations of in vivo PET studies (1, 26) , these experiments revealed that in the absence of plaques, PiB accumulation was limited to highlighting blood vessels. In the absence of congophilic angiopathy, perivascular accumulation of PiB has been previously reported as representing either a nonspecific interaction (27, 28) or an artifact (28) .
Graphical analysis of 11 C-PiB PET data demonstrated no significant difference in white matter DVR values between HCs and patients with dementia. As previously reported (21) , there was no correlation between neocortical and white matter DVRs, also suggesting that the retention in white matter is nonspecific. DVR values in white matter are higher than 1, potentially indicating some degree of specific binding. Furthermore, on average, white matter DVR values are higher than neocortical DVR values in HCs. There is increased accumulation of interstitial fluid in the white matter of AD patients (27) . This increase could translate into increased accumulation of unbound (free) 11 C-PiB in AD patients. Neither 11 C-PiB DVR nor clearance from white matter in AD patients was significantly different from HCs or patients with other dementias, making it unlikely that 11 C-PiB retention is a consequence of these reported increases in interstitial fluid. Previous reports suggest that messenger RNA expression of Ab precursor protein (APP) isoforms is 2-fold higher in the white matter of both HCs and AD patients than in the gray matter (29) . APP plays an important role in response to injury (30) ; the expression of both Ab and APP is increased in white matter after brain trauma (31) , sometimes presenting diffuse Ab deposits similar to those observed in healthy elderly and AD individuals. Binding to APP has also been proposed as an explanation for 11 C-PiB retention in white matter. Recent MRI studies have shown not only reductions in the white matter volumes in AD patients (32) but also mainly reductions in fractal and relative anisotropy as assessed by diffusion tensor imaging, suggestive of Wallerian degeneration or regression of axonal processes associated with neuronal death (33, 34) . Axonal damage and vascular degenerative disease are usually accompanied by increases in APP (35) . Nevertheless, in the present study no significant differences were found in white matter DVR values between AD patients and HCs. Western blot analysis indicated that despite very high concentrations of APP in the white matter of both HCs and AD patients, no specific binding was detected in respective brain homogenates, and no Ab deposition was visualized by either IHC or IF. Clearance rates for white matter, despite being significantly slower than those for gray matter, were no different among HCs and AD and DLB patients. Regional cerebral blood flow in white matter is 2.0-2.4 times lower than regional cerebral blood flow in the neocortex (36) . Delays in delivery (37) and slower clearance of tracers (38) are typically described in white matter regions; therefore, slower 11 CPiB clearance from white matter may contribute to a DVR value higher than 1 in all subjects examined. Furthermore, in all subjects examined, 11 C-PiB clearance in gray matter was significantly faster than in white matter regions. As in the case of HCs, before the end of the 90-min PET scan, the retention in gray matter is much lower than in white matter, giving the impression that white matter retention in HCs is higher than that in the other groups.
CONCLUSION
Our studies demonstrate that 3 H-PiB binds nonspecifically to white matter in postmortem brain homogenates and fails to stain white matter tissue sections, suggesting that 11 C-PiB retention in white matter is nonspecific and may be attributable to a slower regional clearance of the radiotracer. Time-activity curves demonstrate no difference in 11 C-PiB clearance rates in white matter of all patients analyzed. Time-activity curves demonstrate uptake and clearance of 11 C-PiB in frontal cortex (A) and white matter (B). There is greater retention of PiB in frontal cortex of AD patients and to lesser extent in DLB patients than in HCs. In contrast, there was no significant difference in rate of 11 C-PiB clearance in all groups analyzed. SUV 5 standardized uptake value.
